Patents by Inventor Tao Han

Tao Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9947769
    Abstract: Structures for spacers in a device structure for a field-effect transistor and methods for forming spacers in a device structure for a field-effect transistor. A first spacer is located adjacent to a vertical sidewall of a gate electrode, a second spacer is located between the first spacer and the vertical sidewall of the gate electrode, and a third spacer is located between the second spacer and the vertical sidewall of the gate electrode. The first spacer has a higher dielectric constant than the second spacer. The first spacer has a higher dielectric constant than the third spacer. The third spacer has a lower dielectric constant than the second spacer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: April 17, 2018
    Assignee: GLOBALFOUNDRIES Inc.
    Inventors: Tao Han, Zhenyu Hu, Jinping Liu, Hsien-Ching Lo, Jianwei Peng
  • Publication number: 20180069792
    Abstract: A packet processing method, and a device and a system includes receiving, by a provider edge (PE) device, a first virtual extensible local area network (VxLAN) encapsulated packet sent by a network virtualization edge (NVE) device, where the PE device and the NVE device are located in a same data center (DC), and the first VxLAN encapsulated packet includes a first VxLAN network identifier (VNI); parsing, by the PE device, the first VxLAN encapsulated packet to obtain the first VNI; obtaining, according to a correspondence between a VNI and a virtual routing and forwarding (VRF) table, a first VRF table that corresponds to the first VNI; searching, by the PE device, the first VRF table for a route according to a destination Internet Protocol (IP) address of the first VxLAN encapsulated packet; and forwarding the first VxLAN encapsulated packet.
    Type: Application
    Filed: October 27, 2017
    Publication date: March 8, 2018
    Inventors: Yuan Gao, Tao Han, Weilian Jiang
  • Patent number: 9907775
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of cytopathic diseases. Cytopathic diseases may be caused by a variety means such as viral infections like HIV and AIDS in a mammalian subject. The methods and compositions of the invention are effective for inhibiting de novo HIV infection, upregulating viral expression from latent provirus, inhibiting HIV-induced cytopathic effects, down regulating the HIV receptor, increasing ThI cytokine expression, and decreasing Th2 cytokine expression. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent such as those used in HAART protocols or therapeutic agents used to treat opportunistic infections due to HIV in mammalian subjects.
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: March 6, 2018
    Assignee: BIOSUCCESS BIOTECH COMPANY
    Inventors: Zheng Tao Han, Richard L. Chang
  • Publication number: 20180026164
    Abstract: A method for preparing a light emitting diode chip, the method including: 1) providing a substrate; 2) growing an n-type semiconductor layer, an active layer and a p-type semiconductor layer on the substrate sequentially in that order; 3) forming a step including an upper horizontal end surface, a lower horizontal end surface and a step surface in the n-type semiconductor layer, the active layer and the p-type semiconductor layer; 4) growing a transparent conductive layer on the upper horizontal end surface, and forming an etching hole in the middle of the transparent conductive layer; 5) forming an N electrode on the lower horizontal end surface, and forming a P electrode in the etching hole; 6) growing a metal catalyst layer on the light emitting diode chip; and 7) forming a fluorinated graphene protective layer on the metal catalyst layer.
    Type: Application
    Filed: September 29, 2017
    Publication date: January 25, 2018
    Inventors: Peng XIE, Lingfeng YIN, Tao HAN, Jiangbo WANG, Peng LI
  • Patent number: 9871376
    Abstract: The invention provides a global optimization and dispatching method based on time scales. The method uses a target value system and a dispatch model. The global optimization and dispatching method takes input from the results from a variety of subtopics. The methods provide adjustment and optimization in accordance with the time scales that are given in the sub goal of each sub topic: long-term, mid-long-term, short-term, ultra short term and real time optimization. Smart distribution grid can improve operational efficiency, integrated application of new elements in the distribution network of distribution energy network, micro grid, energy storage device and non-linear loads. This invention is fully adapted to the smart grid trends, with a good prospective.
    Type: Grant
    Filed: June 10, 2014
    Date of Patent: January 16, 2018
    Assignees: NIANRI Technology Development Limited Company, State Grid Electric Power Research Institute, JIANGSU ELECTRIC POWER COMPANY, State Grid Corporation of China
    Inventors: Haodong Shen, Peifeng Shen, Tingli Chen, Kai Chen, Yalin Liu, Hong Zhu, Junjing Zhang, Jing Xiao, Hongwei Du, Tao Han, Wenlu Ji, Xing Luo, Wen Lu, Lin Wu, Rina Saqi
  • Publication number: 20170359253
    Abstract: A link protection method in a software-defined networking (SDN), a corresponding switching device and network controller, where the method includes receiving, by a first switching device in the SDN, first information from a network controller in the SDN and link protection information, where the first information establishes a communication link between the first switching device and a destination device, and the link protection information instructs the first switching device to proactively perform primary-to-secondary link switching when a link is faulty, establishing, by the first switching device, the communication link with the destination device according to the first information, and determining, by the first switching device according to the link protection information, that the first switching device proactively performs the primary-to-secondary link switching.
    Type: Application
    Filed: August 3, 2017
    Publication date: December 14, 2017
    Inventors: Peilin Yang, Hengcheng Zhang, Tao Han
  • Patent number: 9831098
    Abstract: Methods for fabricating integrated circuits are provided. In one example, a method for fabricating an integrated circuit includes forming an isolation trench between two fin structures on an integrated circuit substrate, forming a flowable film in the isolation trench using a flowable chemical vapor deposition process, and annealing the flowable film to form a silicon oxide dielectric layer in the isolation trench. The annealing is performed at a temperature of less than about 200° C. with a process gas including N2 and H2O2.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: November 28, 2017
    Assignee: GLOBALFOUNDRIES, INC.
    Inventors: Xinyuan Dou, Sukwon Hong, Satyajit Shinde, Sandeep Gaan, Tao Han, Carlos Chacon, Shimpei Yamaguchi
  • Publication number: 20170337088
    Abstract: Application relationships may be categorized and managed at a service layer, such as creating application relationship, updating application relationship, retrieving application relationship, deleting application relationship, or discovering application relationship. Services may be based on application relationship awareness.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 23, 2017
    Inventors: Chonggang WANG, Qing LI, Hongkun LI, Zhuo CHEN, Tao HAN, Paul L. RUSSELL
  • Publication number: 20170319533
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.
    Type: Application
    Filed: July 25, 2017
    Publication date: November 9, 2017
    Applicant: Biosuccess Biotech Co. Ltd.
    Inventors: Hung-Fong CHEN, Zheng Tao HAN
  • Publication number: 20170324580
    Abstract: Embodiments of the present disclosure provide a failure protection method based on a ring protection link, a device, and a system, and nodes in the ring protection link include a forwarding device in an SDN. The method includes: receiving, by a network controller, a high-priority failure message sent by a first node, where the failure message includes information used to indicate a failure; obtaining, according to the failure message, data information about port state changes that are of the nodes and that are caused by the failure; and sending a high-priority switching message to each of the nodes, so that each of the nodes updates a local MAC address table according to the switching message, where the switching message includes the data information about port state changes that are of the nodes and that are caused by the failure.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Luxiao SUN, Tao HAN, Jiuming LI
  • Patent number: 9762362
    Abstract: Frame structures may be designed and channels may be allocated in a manner to support multi-hop for fully distributed and infrastructure-less peer-to-peer communications in proximity. Frame structures may have a dedicated multi-hop period near the end of a superframe.
    Type: Grant
    Filed: March 11, 2015
    Date of Patent: September 12, 2017
    Assignee: Convida Wireless, LLC
    Inventors: Hongkun Li, Zhuo Chen, Chonggang Wang, Qing Li, Paul L. Russell, Jr., Tao Han
  • Patent number: 9750713
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: September 5, 2017
    Assignee: Biosuccess Biotech Co. Ltd.
    Inventors: Hung-Fong Chen, Zheng Tao Han
  • Publication number: 20170224648
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester in combination with G-CSF or in combination with EPO, are provided for the treatment of cytopenia in mammalian subjects. The compositions and methods also reduce the duration of cytopenia such as neutropenia, thrombocytopenia, and/or anemia.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 10, 2017
    Applicant: BIOSUCCESS BIOTECH CO., LTD.
    Inventor: Zheng Tao HAN
  • Publication number: 20170151205
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of cytopathic diseases. Cytopathic diseases may be caused by a variety means such as viral infections like HIV and AIDS in a mammalian subject. The methods and compositions of the invention are effective for inhibiting de novo HIV infection, upregulating viral expression from latent provirus, inhibiting HIV-induced cytopathic effects, down regulating the HIV receptor, increasing ThI cytokine expression, and decreasing Th2 cytokine expression. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent such as those used in HAART protocols or therapeutic agents used to treat opportunistic infections due to HIV in mammalian subjects.
    Type: Application
    Filed: February 10, 2017
    Publication date: June 1, 2017
    Applicant: BIOSUCCESS BIOTECH COMPANY, LTD.
    Inventors: Zheng Tao HAN, Richard L. CHANG
  • Patent number: 9636317
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms or sequelae of disease. Chronic and acute conditions may be due to viral infections such as HIV and AIDS, neoplastic diseases stroke, kidney disease, urinary incontinence, autoimmune disorders, Parkinson's disease, prostate hypertrophy, aging, or the treatment of such diseases. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools against acute and chronic conditions in mammalian subjects.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: May 2, 2017
    Assignee: Biosuccess Biotech Co. Ltd.
    Inventors: Zheng Tao Han, Hung-Fong Chen
  • Publication number: 20170087112
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment and prevention of stroke and the sequelae of stroke. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools to treat or prevent stroke and the long term effects of stroke in mammalian subjects.
    Type: Application
    Filed: December 7, 2016
    Publication date: March 30, 2017
    Applicant: Biosuccess Biotech Co. Ltd.
    Inventors: Zheng Tao HAN, Hung-Fong CHEN
  • Patent number: 9603825
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of cytopathic diseases. Cytopathic diseases may be caused by a variety means such as viral infections like HIV and AIDS in a mammalian subject. The methods and compositions of the invention are effective for inhibiting de novo HIV infection, upregulating viral expression from latent provirus, inhibiting HIV-induced cytopathic effects, down regulating the HIV receptor, increasing ThI cytokine expression, and decreasing Th2 cytokine expression. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent such as those used in HAART protocols or therapeutic agents used to treat opportunistic infections due to HIV in mammalian subjects.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: March 28, 2017
    Assignee: BIOSUCCESS BIOTECH COMPANY
    Inventors: Zheng Tao Han, Richard L. Chang
  • Publication number: 20170086326
    Abstract: An electronic device enclosure includes a chassis, a bracket, a shaft and a supporting member. The bracket is rotatably connected to the chassis through the shaft. The supporting member is sheathed with the shaft. Two opposite ends of the supporting member are respectively fixed to the chassis and the bracket. When the bracket rotates in a first direction relative to the chassis, the supporting member is elastically deformable to support the bracket preventing the bracket from rotating towards a second direction relative to the chassis. And the first direction is opposite to the second direction.
    Type: Application
    Filed: October 12, 2015
    Publication date: March 23, 2017
    Inventors: YONG PENG, HE-TAO HAN, JUN-HUA TAN, XIAO-ZHONG JING, YI-SHENG LIN, CHUNG CHAI, LIANG-CHIN WANG
  • Publication number: 20170071892
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment and prevention of stroke and the sequelae of stroke. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools to treat or prevent stroke and the long term effects of stroke in mammalian subjects.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Applicant: Biosuccess Biotech Co. Ltd.
    Inventors: Zheng Tao HAN, Hung-Fong CHEN
  • Patent number: 9550722
    Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment and prevention of stroke and the sequelae of stroke. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools to treat or prevent stroke and the long term effects of stroke in mammalian subjects.
    Type: Grant
    Filed: September 12, 2013
    Date of Patent: January 24, 2017
    Assignee: Biosuccess Biotech Co. Ltd.
    Inventors: Zheng Tao Han, Hung-Fong Chen